Why Justice Department appeal on morning-after pill is ironic

In 2011, the Health and Human Services secretary overruled the FDA on its determination that there should be no age restrictions on buying morning-after pills. Now Justice is saying that FDA should be setting the rules, not a federal judge. 

|
Teva Women's Health/AP
This undated image made available by Teva Women's Health shows the packaging for their Plan B One-Step (levonorgestrel) tablet, one of the brands known as the "morning-after pill."

The Justice Department’s decision to appeal a federal judge’s order removing age restrictions on buying morning-after pills keeps the politically charged issue of emergency contraception in the spotlight.

The decision, announced Wednesday night, does not affect the Food and Drug Administration’s rule announced Tuesday that lowers the age limit on the purchase of the most widely known morning-after pill by people as young as 15 without prescription.

The new age limit on Plan B One-Step, down from 17, goes into effect immediately.

In federal court, the debate centers on who determines the rules regarding availability of a medication, including whether there should be any age limit at all. In a letter to District Judge Edward Korman of New York, US Attorney Loretta Lynch said he had overstepped his authority.

“The public properly relies upon FDA classification of drugs as nonprescription as a reflection of the agency’s judgment regarding the safety and proper use of a drug without a doctor’s prescription,” Ms. Lynch wrote, according to USA Today. “The public interest will not be served by reclassification of drugs as nonprescription by order of a court, without appropriate agency decisionmaking procedures being followed.”

The irony in her statement is that the FDA had determined in 2011 that age restrictions on availability of the morning-after pill were unnecessary, based on scientific research – a conclusion cited by Judge Korman in his April 5 ruling. But in December 2011, Health and Human Services Secretary Kathleen Sebelius overruled the agency and barred the drug’s sale to girls under age 17, citing a lack of evidence it was safe. On Tuesday, the FDA announced that it had approved over-the-counter sale of one type of pill, Plan B One-Step, to people aged 15 and older.

It was that original determination by the FDA, back in 2011, that formed the basis of Judge Korman’s ruling. In his decision, he blamed presidential politics for Secretary Sebelius’s unprecedented step of overruling the FDA.

“The motivation for the secretary’s action was obviously political,” the judge wrote. “It was an election year decision that many public health experts saw as a politically motivated effort to avoid riling religious groups and others opposed to making birth control available to girls.”

President Obama won reelection, but the politics of the morning-after pill are still very much alive. The Justice Department decision to appeal Korman’s ruling – and request an injunction preventing it from taking effect – met with immediate response from interest groups.

The anti-abortion Susan B. Anthony List applauded the Obama administration’s decision to appeal Korman’s ruling, while reinforcing its opposition to the FDA’s new rule.  

"Whether they are 15 or 17, teens need the protection and support that comes with parental and doctor involvement," SBA List President Marjorie Dannenfelser said in a statement.

The Planned Parenthood Federation of America reaffirmed its position that the morning-after pill should be available to people of all ages.

“Age barriers to emergency contraception are not supported by science, and they should be eliminated,” federation president Cecile Richards said in a statement. 

You've read  of  free articles. Subscribe to continue.
Real news can be honest, hopeful, credible, constructive.
What is the Monitor difference? Tackling the tough headlines – with humanity. Listening to sources – with respect. Seeing the story that others are missing by reporting what so often gets overlooked: the values that connect us. That’s Monitor reporting – news that changes how you see the world.

Dear Reader,

About a year ago, I happened upon this statement about the Monitor in the Harvard Business Review – under the charming heading of “do things that don’t interest you”:

“Many things that end up” being meaningful, writes social scientist Joseph Grenny, “have come from conference workshops, articles, or online videos that began as a chore and ended with an insight. My work in Kenya, for example, was heavily influenced by a Christian Science Monitor article I had forced myself to read 10 years earlier. Sometimes, we call things ‘boring’ simply because they lie outside the box we are currently in.”

If you were to come up with a punchline to a joke about the Monitor, that would probably be it. We’re seen as being global, fair, insightful, and perhaps a bit too earnest. We’re the bran muffin of journalism.

But you know what? We change lives. And I’m going to argue that we change lives precisely because we force open that too-small box that most human beings think they live in.

The Monitor is a peculiar little publication that’s hard for the world to figure out. We’re run by a church, but we’re not only for church members and we’re not about converting people. We’re known as being fair even as the world becomes as polarized as at any time since the newspaper’s founding in 1908.

We have a mission beyond circulation, we want to bridge divides. We’re about kicking down the door of thought everywhere and saying, “You are bigger and more capable than you realize. And we can prove it.”

If you’re looking for bran muffin journalism, you can subscribe to the Monitor for $15. You’ll get the Monitor Weekly magazine, the Monitor Daily email, and unlimited access to CSMonitor.com.

QR Code to Why Justice Department appeal on morning-after pill is ironic
Read this article in
https://www.csmonitor.com/USA/Politics/DC-Decoder/2013/0502/Why-Justice-Department-appeal-on-morning-after-pill-is-ironic
QR Code to Subscription page
Start your subscription today
https://www.csmonitor.com/subscribe